Antiviral activity of Clinacanthus siamensis Bremek ethanolic extract against dengue virus serotype 2 infection

Dengue virus (DENV) infection causes dengue fever and can progress to severe, life-threatening diseases. Currently, no specific antiviral therapy is available, and although vaccines exist, their variable efficacy across DENV serotypes raises safety concerns. Therefore, the identification of effective antiviral agents remains critical for reducing disease severity and limiting viral transmission. This study evaluated the antiviral activity of the Thai medicinal herb Clinacanthus siamensis against DENV infection. An ethanolic extract of C. siamensis was evaluated using in vitro DENV infection assays and demonstrated significant antiviral activity, with an IC₅₀ value of 19.32 µg/mL. The inhibitory mechanism of the extract was evaluated across multiple stages of the viral life cycle using time-of-addition experiments, including pre-treatment, co-treatment, and post-infection conditions, in which the virus was exposed to the extract before, during, and after viral entry, respectively. The pre-treatment condition demonstrated the highest level of inhibition, with the extract reducing viral protein levels to 92.79 ± 7.74%, 60.30 ± 9.79%, and 12.52 ± 10.18% at concentrations of 15.625, 31.25, and 62.5 µg/mL, respectively. These findings suggest that the extract exerts its antiviral activity predominantly at an early stage of infection. This observation was further supported by virus-binding assays, which demonstrated that pretreatment of viral particles with the extract impaired their subsequent ability to bind to host cells, suggesting a direct effect on viral particles that may contribute to reduced viral infectivity. In addition, the bioactive constituents of the extract were characterized using LC–MS/MS analysis, which identified two compounds with reported antiviral activity, including isoferulic acid and luteolin, that may contribute to the observed anti-DENV effects. These findings demonstrate that C. siamensis possesses potent anti-DENV activity by reducing viral infectivity at an early stage of infection and highlights the potential of C. siamensis for future development as an affordable therapeutic candidate against DENV​ infection.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-21
DOI
https://doi.org/10.1038/s41598-026-80262-1
Primary Topic
Medicinal Plant Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antiviral activity of Clinacanthus siamensis Bremek ethanolic extract against dengue virus serotype 2 infection

Angkhana Inta, Thawornchai Limjindaporn, George S. Baillie, Saruda Thongyim et al.
Scientific Reports
Medicinal Plant Studies
article

Antiviral activity of Clinacanthus siamensis Bremek ethanolic extract against dengue virus serotype 2 infection

Angkhana Inta, Thawornchai Limjindaporn, George S. Baillie, Saruda Thongyim, Aussara Panya, Pa-thai Yenchitsomanus, Natthanich Boonsatit, Somluethai Fungfueang
article en

Abstract

Dengue virus (DENV) infection causes dengue fever and can progress to severe, life-threatening diseases. Currently, no specific antiviral therapy is available, and although vaccines exist, their variable efficacy across DENV serotypes raises safety concerns. Therefore, the identification of effective antiviral agents remains critical for reducing disease severity and limiting viral transmission. This study evaluated the antiviral activity of the Thai medicinal herb Clinacanthus siamensis against DENV infection. An ethanolic extract of C. siamensis was evaluated using in vitro DENV infection assays and demonstrated significant antiviral activity, with an IC₅₀ value of 19.32 µg/mL. The inhibitory mechanism of the extract was evaluated across multiple stages of the viral life cycle using time-of-addition experiments, including pre-treatment, co-treatment, and post-infection conditions, in which the virus was exposed to the extract before, during, and after viral entry, respectively. The pre-treatment condition demonstrated the highest level of inhibition, with the extract reducing viral protein levels to 92.79 ± 7.74%, 60.30 ± 9.79%, and 12.52 ± 10.18% at concentrations of 15.625, 31.25, and 62.5 µg/mL, respectively. These findings suggest that the extract exerts its antiviral activity predominantly at an early stage of infection. This observation was further supported by virus-binding assays, which demonstrated that pretreatment of viral particles with the extract impaired their subsequent ability to bind to host cells, suggesting a direct effect on viral particles that may contribute to reduced viral infectivity. In addition, the bioactive constituents of the extract were characterized using LC–MS/MS analysis, which identified two compounds with reported antiviral activity, including isoferulic acid and luteolin, that may contribute to the observed anti-DENV effects. These findings demonstrate that C. siamensis possesses potent anti-DENV activity by reducing viral infectivity at an early stage of infection and highlights the potential of C. siamensis for future development as an affordable therapeutic candidate against DENV​ infection.

Scientific Reports
Siriraj Hospital (TH), Mahidol University (TH), Chiang Mai University (TH), University of Glasgow (GB)
Medicinal Plant Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon